Hematopoiesis conclusion
Hematopoiesis Overview
Hematopoiesis: The process of blood cell formation, comprising two main types:
Intramedullary Hematopoiesis: Occurs within the bone marrow.
Extramedullary Hematopoiesis: Takes place outside the bone marrow, primarily in the liver and spleen in adults. This can lead to complications like hepatosplenomegaly if it becomes necessary.
The Spleen
Functionality:
A versatile organ located on the left side of the body under the rib cage.
Filters blood and produces red blood cells (RBCs), white blood cells (WBCs), and platelets (PLTs) when required.
Structure:
Approximately the size of a fist and weighs about 8 oz.
Composed of red pulp, which primarily filters RBCs, and white pulp, which processes lymphocytes. The marginal zone stores WBCs and PLTs.
Role in Hematopoiesis:
Acts as a secondary hematopoietic organ, starting hematopoiesis at 2-3 months of gestation and ceasing at birth.
Exclusive to bone marrow for hematopoiesis thereafter unless necessary.
Immunological Role of the Spleen
The spleen is the largest secondary lymphoid organ, playing a vital role in:
Phagocytic activity for encapsulated organisms, such as:
Haemophilus influenzae
Streptococcus pneumoniae
Neisseria meningitidis
Producing opsonizing antibodies that strip the capsule from bacterial surfaces.
Splenectomy:
The removal of the spleen may be necessary in cases of enlargement, injury, or limited function, especially in leukemic conditions.
Following splenectomy, the liver compensates for some of the spleen's functions.
Post-Splenectomy Changes
Howell-Jolly Bodies: Noted on peripheral blood smears post-splenectomy, indicating impaired splenic function in filtering blood cells.
Myeloid:Erythroid Ratio (M:E Ratio) in Bone Marrow
The M:E Ratio indicates the ratio of myeloid to erythroid cells and serves as a marker of hematopoietic activity:
Composition:
The bone marrow comprises yellow and red marrow, containing erythroid (RBCs), myeloid (WBCs), and megakaryocytes (platelets).
Normal Ratio: Typically, a ratio of 3:1 to 4:1 is observed in healthy adults.
Alterations in the M:E Ratio
Increased Ratio: Indicative of conditions such as:
Infection
Chronic Myeloid Leukemia (CML)
Erythroid hypoplasia
Decreased Ratio: Can occur with:
Reduced leukopoiesis
Normoblastic hyperplasia
Clinical Significance:
Changes in M:E ratio can indicate hematologic disease. For instance, anemia triggers increased erythropoietin (EPO) production from the kidneys, stimulating red blood cell production, potentially leading to the release of immature red blood cells (e.g., reticulocytes) into circulation.